U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Chlorinated Drinking-Water; Chlorination by-Products; Some Other Halogenated Compounds; Cobalt and Cobalt Compounds. Lyon (FR): International Agency for Research on Cancer; 1991. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 52.)

Cover of Chlorinated Drinking-Water; Chlorination by-Products; Some Other Halogenated Compounds; Cobalt and Cobalt Compounds

Chlorinated Drinking-Water; Chlorination by-Products; Some Other Halogenated Compounds; Cobalt and Cobalt Compounds.

Show details

Bromodichloromethane

1. Chemical and Physical Data

1.1. Synonyms

Chem. Abstr. Services Reg. No.: 75-27-4

Chem. Abstr. Name: Bromodichloromethane

IUPAC Systematic Name: Bromodichloromethane

Synonyms: Dichlorobromomethane; dichloromonobromomethane; monobromodichloromethane

1.2. Structural and molecular formulae and molecular weight

Image 006c-1_001

1.3. Chemical and physical properties of the pure substance

  1. Description: Colourless liquid (Verschueren, 1983)
  2. Boiling-point: 90.1°C (Weast, 1989)
  3. Melting-point: -57.1° C (Weast, 1989)
  4. Density. 1.980 at 20/4°C (Weast, 1989)
  5. Spectroscopy data1: Infrared (Sadtler Research Laboratories, 1980, prism [1898], grating [18024]; Pouchert, 1981, 1985a,b), nuclear magnetic resonance (Sadtler Research Laboratories, 1980, proton [6709], C-13 [4023]; Pouchert, 1974,1983) and mass spectral data [1026] (Bunn et al.,1975; Coleman et al., 1984) have been reported
  6. Solubility. Soluble in water (4.5 g/l at 20°C) (Mabey et al., 1982), acetone,ethanol, benzene, chloroform and diethyl ether (Weast, 1989)
  7. Volatility. Vapour pressure, 50 mm Hg at 20°C (Mabey et al., 1982)
  8. Reactivity. Hydrolysis rate at neutral pH, 25°C, K = 5.76 × 10−8 per hour (Mabey et al., 1982)
  9. Octanol/water partition coefficient (P): log P, 2.10 (Chemical Information Systems, 1990)
  10. Conversion factor1: mg/m3 = 6.70 × ppm

1.4. Technical products and impurities

Bromodichloromethane is available at > 97–98% purity, and may be stabilized with potassium carbonate or ethanol (Riedel-de Haën, 1986; American Tokyo Kasei, 1988; Aldrich Chemical Co., 1990).

2. Production, Use, Occurrence and Analysis

2.1. Production and use

(a) Production

Bromodichloromethane has been prepared by treating a mixture of chloroform (see IARC, 1987) and bromoform (see monograph, p. 213) with triethylbenzylammonium chloride and sodium hydroxide (Fedoryński et al., 1977).

(b) Use

Bromodichloromethane can be used in organic synthesis, such as in the preparation of phenylbromodichloromethylmercury, which has been widely used for the generation of dichlorocarbene (Fedoryński et al., 1977; Sittig, 1985).

Bromodichloromethane is currently used only as a standard in the analysis of drinking-water (Strobel & Grummt, 1987).

(c) Regulatory status and guidelines

Standards have been established for trihalomethanes (including bromodichloromethane) in drinking-water (see monograph on Chlorinated drinking-water, p. 59) in several countries.

2.2. Occurrence

(a) Natural occurrence

Mean levels of bromodichloromethane in the tissues of a number of temperate marine microalgae (Ascophyllum nodosum, Fucus vesiculosis, Enteromorpha linza, Ulva lacta, Gigartina stellata) ranged from 7 to 22 ng/g dry weight; the algae release this compound into seawater, from which it may be released to the atmosphere (Gschwend et al., 1985).

Macroalgae collected near the Bermuda Islands (Fucales sargassum) and at the Cape of Good Hope (Laminariales laminaria) showed a specific pattern of emissions of volatile organohalides into the surrounding air. The main components were bromoform, bromodichloromethane, chlorodibromomethane; a minor component was bromoethane (Class et al, 1986).

(b) Multimedia exposure assessment

In a study of exposures to volatile organic compounds on two US university campuses in 1980, bromodichloromethane levels in personal breathing-zone air samples ranged from not detected to 3.7 μg/m3 for 11 students at Lamar University, Texas, and from not detected to 4.3 μg/m3 for six students at the University of North Carolina. It was detected in the ambient air of 64% of the Lamar University samples at a mean concentration of 1.23 μg/m3 and in 17% of the University of North Carolina samples at 0.83 μg/3. It was not detected in any of the collected breath samples. Tap-water samples contained mean bromodichloromethane levels of 21 ng/ml (range, 13–44) for the Lamar University students and 17 ng/ml (range, 15–20) for those at the University of North Carolina. The authors concluded that drinking-water was an important contributor to total intake of bromodichloromethane from air and water, assuming daily intakes of 10 m3 of air and 1 litre of drinking-water. The water accounted for 76% of the bromodichloromethane intake (Wallace et al., 1982).

Nine volunteers in New Jersey and three in North Carolina were monitored for exposure to bromodichloromethane in personal air samples, drinking-water, food and breath from July to December 1980. Bromodichloromethane was detected at 0.10–13.40 μg/m3 in 28 (16 at trace) of the 164 breathing zone air samples in New Jersey and at 0.10–3.66 μg/m3 in 12 (seven at trace) of the 60 samples in North Carolina. It was detected in none of the exhaled breath samples: 49 in New Jersey (limit of detection, 0.17–0.20 μg/m3) and 17 in North Carolina (limit of detection, 0.14–2.20 μg/m3). The drinking-water of the New Jersey volunteers contained bromodichloromethane levels ranging from 4.40 to 42.00 μg/l in home samples and from 0.02 to 37.00 μg/l in workplace samples; it was present in all of the 75 home samples at a median concentration of 18.00 μg/l and in 44 of the 45 workplace samples at a median concentration of 13.0 μg/l. In North Carolina, home drinking-water samples contained bromodichloromethane levels ranging from 12.0 to 20.0 μg/l and those in the workplace from 0.02 to 20.0 μg/l; it was present in all of the 30 home samples at a median concentration of 16 μg/l and in 17 of the 18 workplace samples at a median concentration of 14 μg/l. Bromodichloromethane was detected in composite beverage samples at 1.0 μg/l; it was not detected in composite dairy, meat or fatty food samples. The authors conclude that at least 75% of the volunteers' exposure to bromodichloromethane was contributed by drinking-water and that beverages supplied a significant fraction of the intake (Wallace et al, 1984).

(c) Air

The volatilization half-time of bromodichloromethane from rivers and streams has been estimated to range from 33 min to 12 days, depending on turbulence and temperature. A typical half-time, based on actual data, was 35 h (Kaczmar et al., 1984).

Air samples were collected in 1978–79 from eight covered swimming pools in Bremen, Germany, to determine the concentration of bromodichloromethane. The range of means, measured from the surface up to 2 m, in the four pools in which a mixed water source was used was 0.2–22μg/m3 (total range, 0.1–38 μg/m3). The range of means in the four pools in which a groundwater source was used was 0.6–22 μg/m3 (total range, 0.1–39 μg/m3). Release of volatile compounds into the air depended on water and air temperature, concentration in the water, and intensity of air circulation (Lahl et al., 1981).

Ullrich (1982) studied the organohalogen compound concentrations in the air of four public indoor swimming pools in western Berlin. Mean concentrations of bromodichloromethane ranged from 36 to 210 μg/m3.

In the USA, air samples collected 2 cm above the surface of five outdoor pools contained 1–7 μg/m3 bromodichloromethane; those above four indoor pools contained 1–14 μg/m3; and those above four spas (whirlpools or hot tubs) contained < 0.1–90 μg/m3. Samples collected 2 m above the surface contained < 0.1 μg/m3, < 0.1–10 μg/m3 and < 0.1–10 μg/m3, respectively (Armstrong & Golden, 1986).

In a review of data on the presence of volatile organic chemicals in the atmosphere of the USA in 1970–80, a median concentration of 1.2 μg/m3 bromodichloromethane was reported for the 17 urban/suburban data points examined and 0.11 μg/m2 for industrial areas (nine data points) (Brodzinsky & Singh, 1983).

Bromodichloromethane levels in air samples collected in 1982–85 over the Atlantic Ocean were 0.1–1 ppt (0.7–6.7 ng/m3); baseline levels of biogenic bromodichloromethane in air were 0.2–0.6 ppt (1.3–4.0 ng/m3). Air samples collected in 1985 from a forest area in southern Germany contained 0.5 ppt (3.4 ng/m3) bromodichloromethane (Class et al., 1986).

According to the Toxic Chemical Release Inventory (National Library of Medicine, 1989), 115 kg of bromodichloromethane were released to ambient air in one US location. No release to media other than air was reported.

(d) Water and sediments

The formation of trihalomethanes in drinking-water and the effects of temperature and pH have been discussed extensively (Williams, 1985; see also the monograph on Chlorinated drinking-water, pp. 56 et seq.).

Bromodichloromethane has been measured or detected in many drinking-water systems, both in samples collected at treatment facilities or along the distribution system (Table 1) and in samples collected from natural and untreated water sources (Table 2). Concentrations in treated drinking-water typically ranged from 1 to 50 μg/l (with higher or lower values in some locations), compared with concentrations in untreated (natural) waters, which are typically less than 1 μg/l.

Table 1.. Bromodichloromethane concentrations in treated drinking-water 1973–89.

Table 1.

Bromodichloromethane concentrations in treated drinking-water 1973–89.

Table 2.. Bromodichloromethane concentrations in untreated (natural) water 1973–89.

Table 2.

Bromodichloromethane concentrations in untreated (natural) water 1973–89.

Rook (1974) demonstrated that bromodichloromethane, observed at concentrations ranging from 4.2 to 20 μg/l following chlorination of stored surface waters, was a product of chlorination of the humic substances in natural waters.

Bromodichloromethane was detected (but not quantified) by headspace analysis of six of ten Pacific seawater samples collected in 1983; it was not detected in the corresponding marine air samples (Hoyt & Rasmussen, 1985).

Bromodichloromethane was found in water samples collected at various stages of water treatment: not detected (< 0.1 μg/l) in raw river water; 6.3 μg/l in river water treated with chlorine and alum; 18.0 μg/l in three-day-old settled water; 21.9 μg/l in water flowing from settled areas to filters; 18.0 μg/l in the filter effluent; and 20.8 μg/l in finished water (Bellar et al, 1974a,b).

According to the US Environmental Protection Agency STORET system, concentrations of bromodichloromethane in 143 samples of surface water in 1970–79 ranged from 0.1 to 1 μg/l in 66% of the samples, 1–10 μg/l in 31% of the samples and 10–100 μg/l in 3% of the samples (Perwak et al, 1980).

The US Environmental Protection Agency estimated that 832 tonnes of bromodichloromethane were generated in the USA in 1978 by water chlorination. On the basis of the 1976 National Organic Monitoring Survey, the general population was estimated to be exposed to 20 μg bromodichloromethane per day from drinking-water, assuming a median concentration of 14 μg/l and a water intake of 1.651 per day; assuming a maximal concentration of 180 μg/l and an intake of 2.181 per day, the daily exposure increased to 400 μg per day (Perwak et al., 1980). In a later investigation by the US Environmental Protection Agency STORET data base, analysis of 19 550 water samples revealed a mean bromodichloromethane concentration of 11.14 μg/l (range, 0–10 133 μg/l); analysis of 581 sediment samples revealed a mean of 10.8 μg/kg (range, 0–55 μg/kg) (US Environmental Protection Agency, 1985).

In the 1982 US Nationwide Urban Runoff Program, bromodichloromethane was detected in samples from one of the 15 reporting cities at a concentration of 2 μg/l (Cole et al, 1984).

Samples of finished water collected in 1976 from the clear well storage area at the Huron, South Dakota, USA, water-treatment plant contained 42 μg/l bromodichloromethane. Changing the location of the prechlorination dose (from the presedimentation/chemical addition station to the recarbonation basin) or changing the pH did not substantially affect the bromodichloromethane concentration (Harms & Looyenga, 1977).

Although the levels found were not reported, a detection frequency of 10% for concentrations > 1 μg/l was reported for bromodichloromethane in water samples collected in 1976 from the Delaware, Schuylkill and Lehigh Rivers in the USA. Levels in raw water at treatment plants in Trenton, Torresdale-Philadelphia and Queenslane-Philadelphia increased from < 1 μg/l to 1,10 and 6 μg/l, respectively, as a result of the chlorination process (DeWalle & Chian, 1978).

Tap-water samples collected between January 1977 and March 1978 in Osaka, Japan, contained bromodichloromethane at levels of 5.8, 7.5 and 14.0 μg/l at seasonal mean water temperatures of 7.4°C, 15.8°C and 25.4°C, respectively. An increase of approximately 0.5 in pH to control pipe corrosion resulted in bromodichloromethane concentrations of 7.8, 9.6 and 14.6 μg/l at similar mean water temperatures (Kajino & Yagi, 1980).

Bromodichloromethane levels in tap water collected at four locations in a Swedish community ranged from 0.84 to 1.2 μg/l; when the treatment facility briefly changed the disinfectant from chlorine to chlorine dioxide, the levels ranged from 0.021 to 0.023 μg/l (detection limit, 0.005 μg/l) (Norin et al, 1981).

Samples of water were collected between August and October 1980 from four supply systems in Sao Paulo State, Brazil. Mean levels of bromodichloromethane were 6.8–15.8 μg/l in treated water (after treatment), 9.8–23.3 μg/l in treated water from the reservoir and 11.5–27.8 μg/l in treated tap water (de Fernicola & de Azevedo, 1984).

Water samples were collected from five outdoor pools, four indoor pools and four spas (whirlpools or hot tubs) in Lubbock, TX, USA. The concentrations of bromodichloromethane in the outdoor pools, which used chlorine-based materials for disinfection were 1–72 μg/l. Two of the indoor pools in which only chlorination was used had levels of 1.5–90 μg/l; one indoor pool in which only bromination (sodium hypobromite) was used had levels of 1–11 μg/l; and the fourth indoor pool, in which chlorination and bromination were alternated, had levels of 1–8 μg/l. The spa in which only chlorination was used had levels of 1–105 μg/l; the two spas in which only bromination was used had levels of < 0.1–21 μg/l; and the spa in which the combination was used had levels of 0.7–13 μg/l. The average concentration of bromodichloromethane in Lubbock, TX, tap water was 1.0 μg/l (Armstrong & Golden, 1986).

Water samples were collected in 1978–79 from eight covered swimming pools in Bremen, Germany, to determine the concentration of bromodichloromethane. The source of fresh water was mixed river and groundwater for four pools and groundwater for four pools. The level of bromodichloromethane in the pools with mixed sources was 1.5 and that in the pools with groundwater, 1.0 μg/l. The range of means of bromodichloromethane in the four pools with a mixed water source was 15–60μg/l (total range, 4–150 μg/l); that in the four pools with a groundwater source was 0.1–25 μg/l (total range, 0.1–76 μg/l) (Lahl et al, 1981).

Kaminski and von Loew (1984) found an average concentration of 0.8 μg/l (max, 2.0 μg/l) bromodichloromethane in 26 indoor pools in western Germany. The concentrations of bromodichloromethane in two thermal spas in which the initial bromide concentration was 0.5–0.7 mg/l were 2.3–23.8 μg/l (Weil et al, 1980).

Scotte (1984) studied the concentrations of organohalogens in the water of 10 covered swimming pools in France. The mean concentrations of bromodichloromethane were 4.5 μg/l in the four pools treated with Surchlor GR 60 (anhydrous sodium dichloroisocyanurate); 11.10 μg/l in the two treated with gaseous chlorine, 14.18 μg/l in the two treated with sodium hypochlorite and 0.5 μg/l in the two treated with bromine.

Effluents from a wastewater treatment plant on Boston Harbor, MA, USA, sampled in 1984 and 1985, contained a mean bromodichloromethane concentration of 4.5 μg/l (range, 0.96–10.3) and had an estimated mass input rate of 4.1 kg/day (Kossik et al, 1986).

Heating water to prepare food has been shown to eliminate a large part of trihalomethanes in the water, as a function of temperature and heating time. Levels of bromodichloromethane were reduced from 44.6 μg/l in tap water to 24.1 μg/l after heating at 80° C for 1 min, to 13.5 μg/l after heating to 100°C, to 10.8 μg/l after boiling for 1 min, and to 4.6 μg/l after boiling for 5 min (Lahl et al, 1982).

(e) Food and beverages

Entz et al. (1982) purchased 39 different food items at retail markets in three geographical areas in the USA and analysed 20 food composites, comprising four groups (dairy, meats, oils-fats, beverages), for bromodichloromethane. It was detected in one dairy composite (milk, ice-cream, cheese and butter) at a concentration of 1.2 μg/l and in two beverage composites at concentrations of 0.3 and 0.6 μg/l. Subsequent analysis of the components of the composites revealed concentrations of 2.3, 3.4 and 3.8 μg/l in three cola soft drinks and 7 μg/kg in butter.

Abdel-Rahman (1982) analysed various US soft drinks for the presence of bromodichloromethane. Cola beverages had mean ranges of 0.9–5.9 μg/l, while other soft drinks had levels of 0.1–3.3 μg/l. Municipal water supplies from which the soft drinks were manufactured were found to contain less than 20 μg/l trihalomethanes.

Uhler and Diachenko (1987) analysed process water and food products from 15 food processing plants located in nine states in the USA, representing 39 food products. Bromodichloromethane was found in seven process waters at levels ranging from < 1 to 14.1 μg/kg, in three soft drinks from one plant at 1.2–2.3 μg/kg and in three ice creams from one plant at 0.6–2.3 μg/kg. The ice-cream plant was the only location at which bromodichloromethane was found in both the process water and the associated food products.

2.3. Analysis

Selected methods for the analysis of bromodichloromethane in air and water are given in Table 3. A variety of analytical methods exist for measuring bromodichloromethane in water. The commonly used methods are based on extraction with solvent followed by gas chromatograph-electron capture detection (US Environmental Protection Agency Method 501–2) (Standing Committee of Analysts, 1980), purge-and-trap, flame ionization detection and microcoulometric gas chromatography (Bellar et al, 1974a,b; Method 501–1), gas chromatography-mass spectrometry and headspace analysis (Otson et al, 1982).

Table 3.. Methods for the analysis of bromodichloromethane.

Table 3.

Methods for the analysis of bromodichloromethane.

The US Environmental Protection Agency methods for analysing water (Methods 8010 and 8240) have also been used for liquid and solid wastes. Volatile components of solid waste samples are first extracted with methanol, prior to purge-and-trap concentration and analysis by gas chromatography-electrolytic conductivity detection (Method 8010) or gas chromatography-mass spectrometry (Method 8240). The detection limit for bromodichloromethane using Method 8010 is 0.10 μg/l, and the practical quantification limit using Method 8240 is 5 μg/l for groundwater and for soil/sediment samples (US Environmental Protection Agency, 1986a,b).

US Environmental Protection Agency Method 624 has also been adapted to the analysis of bromodichloromethane in fish, with an estimated detection limit of 10 μg/kg (Easley et al., 1981).

3. Biological Data Relevant to the Evaluation of Carcinogenic Risk to Humans

3.1. Carcinogenicity studies in animals (Table 4)

Table 4.. Summary of carcinogenicity studies of bromodichloromethane in experimental animals.

Table 4.

Summary of carcinogenicity studies of bromodichloromethane in experimental animals.

(a) Oral administration

Mouse: Groups of 50 male and 50 female B6C3F1 mice, eight weeks old, were given bromodichloromethane (> 99% pure) in corn oil by gavage at 25 or 50 mg/kg bw (males) and 75 or 150 mg/kg bw (females) on five days per week for 102 weeks. Survival at 104 weeks was: males—vehicle control, 34/50; low-dose, 32/50; high-dose, 42/50; females—control, 26/50; low-dose, 13/50; high-dose, 15/50. Decreased survival in female mice was associated in part with tubo-ovarian abscesses (control, 8/50; low-dose, 19/47; high-dose, 18/49). Tubular-cell adenomas of the kidney occurred in 1/49 vehicle control, 2/50 low-dose and 6/50 high-dose male mice and tubular-cell adenocarcinomas occurred in 4/50 high-dose male mice. The proportion of high-dose male mice with renal tubular-cell neoplasms was significantly greater than that in controls (p = 0.022, incidental tumour test). Renal tubular-cell neoplasms were uncommon in control male mice of this strain (historical incidences: study laboratory, 2/299 (0.7%); all National Toxicology Program laboratories, 5/1490 (0.3%)). Hepatocellular adenomas occurred in 1/50 control, 13/48 low-dose and 23/50 high-dose female mice; hepatocellular carcinomas occurred in 2/50 control, 5/48 low-dose and 10/50 high-dose female mice. The proportion of low- and high-dose female mice with hepatocellular neoplasms was significantly greater than that in controls (p < 0.001, incidental tumour test; pairwise comparisons and trend test). Adenomas of the anterior pituitary gland occurred at significantly lower incidence in high-dose female mice (control, 17/44; low-dose, 8/43; high-dose, 3/38; p = 0.006, pairwise comparison, incidental tumour test). Follicular-cell hyperplasia of the thyroid was significantly more common in treated mice, principally in those given the high dose (males: control, 0/48; low-dose, 3/44; high-dose, 5/49; females: vehicle control, 6/50; low-dose, 18/45; high-dose, 21/48) (National Toxicology Program, 1987).

Groups of male and female CBA × C57B1/6 hybrid mice [age unspecified] were given bromodichloromethane [purity unspecified] at 0.04 mg/l (50 males, 50 females), 4.0 mg/l (50 males, 50 females) or 400 mg/l (55 males, 55 females) in the drinking-water for 104 weeks. Seventy-five males and 50 females served as controls. The number of animals surviving to the appearance of the first tumour were: males—control, 63; low-dose, 35; medium-dose, 16; and high-dose, 45; females—control, 34; low-dose, 45; medium-dose, 18; and high-dose, 13 [average survival time and numbers of terminal survivors unspecified]. No tumour occurred at increased incidence in treated mice (Voronin et al., 1987). [The Working Group noted the incomplete reporting of the study.]

Rat: Groups of 50 male and 50 female Fischer 344 rats, eight weeks old, were given bromodichloromethane (> 99% pure) in corn oil at 50 or 100 mg/kg bw by gavage on five days per week for 102 weeks. Survival at 104 weeks was: males—vehicle control, 28/50; low-dose, 36/50; high-dose, 28/50; females—vehicle control, 34/50; low-dose, 27/50; high-dose, 41/50. Adenomatous polyps of the large intestine occurred in 0/50 control, 3/50 low-dose and 33/50 high-dose males; adenocarcinomas of the large intestine occurred in 0/50 control, 11/50 low-dose and 38/50 high-dose males. The proportion of male rats receiving 50 or 100 mg/kg bw bromodichloromethane that had neoplasms of the large intestine was significantly greater than in controls (p < 0.001, incidental tumour test, pairwise comparisons and trend test). Tubular-cell adenomas of the kidney occurred in 0/50 control, 1/50 low-dose and 3/50 high-dose male rats, whereas tubular-cell adenocarcinomas occurred in 10/50 high-dose males. The proportion of high-dose male rats with renal tubular-cell neoplasms was significantly greater than in controls (p < 0.001, incidental tumour test, pairwise comparison and trend test). Renal tubular-cell neoplasms were uncommon in control male rats of this strain (historical incidences: study laboratory, 1/250 (0.4%); all National Toxicology Program laboratories, 8/1448 (0.6%)). Cytomegaly of renal tubular epithelial cells occurred at high incidence in treated male rats but not in control male or treated or control female rats. The proportion of high-dose male rats with adrenal medullary phaeochromocytomas (benign or malignant) was lower than that in controls: control, 18/50; low-dose, 14/50; high-dose, 5/50 (p = 0.003, pairwise comparison by incidental tumour test). Adenomatous polyps of the large intestine occurred in 0/46 control, 0/50 low-dose and 7/47 high-dose female rats, while adenocarcinomas occurred in 0/46 control, 0/50 low-dose and 6/47 high-dose rats. The proportion of high-dose female rats with neoplasms of the large intestine was significantly greater than in controls (p < 0.001, incidental tumour test, pairwise comparisons and trend test). Renal tubular-cell adenomas occurred in 0/50 control, 1/50 low-dose and 6/50 high-dose females, and tubular-cell adenocarcinomas occurred in 9/50 high-dose female rats. The proportion of high-dose female rats with renal tubular-cell neoplasms was significantly greater than in controls (p < 0.001, incidental tumour test, pairwise comparison and trend test). Increased incidences of non-neoplastic lesions of the liver seen in treated females included clear-cell, eosinophilic cytoplasmic, focal cellular and fatty changes. The incidences of neoplasms of the anterior pituitary and of fibroadenomas of the mammary gland were significantly lower in high-dose female rats than in controls (anterior pituitary neoplasms: control, 31/49; low-dose, 20/49; high-dose, 14/49; p < 0.001, incidental tumour test and life table test, pairwise comparison and trend; mammary gland fibroadenomas: control, 20/50; low-dose, 15/50; high dose, 1/50; p < 0.001, incidental tumour test, pairwise comparison and trend) (National Toxicology Program, 1987).

Groups of 58 male and 58 female weanling Wistar rats received bromo-dichloromethane [purity unspecified] at 2.4 g/l (approximately the maximal acceptable level) in the drinking-water for 72 weeks followed by 1.2 g/l for the remainder of their life [average survival time not given]. Twenty-six male and 22 female rats received drinking-water without bromodichloromethane and served as controls. Neoplastic nodules of the liver occurred in 0/18 control and 17/53 treated female rats (p < 0.001, Fisher's exact test). Adenofibrosis of the liver was also observed in 12/53 treated female and 1/47 treated male rats, but not in controls. The proportion of treated rats with lymphosarcomas in comparison to controls was decreased in treated males and increased in treated females (males: control, 14/22; treated, 9/47; p < 0.001, Fisher's exact test; females: control, 2/18; treated, 9/53; p < 0.01, Fisher's exact test). The proportion of treated female rats with pituitary gland or mammary gland tumours [types unspecified] was decreased relative to controls (pituitary tumours: controls, 6/18; treated, 5/53; p < 0.03, Fisher's exact test; mammary gland tumours: controls, 8/18; treated, 3/53;p < 0.001, Fisher's exact test) (Tumasonis et al, 1985). [The Working Group noted that survival-adjusted statistics were not given and the controversial nature of the lesion diagnosed as adenofibrosis.]

(b) Intraperitoneal administration

Mouse: In a screening assay based on the enhanced induction of lung tumours, groups of 20 male strain A/St mice, six to eight weeks old, were injected intraperitoneally three times per week with bromodichloromethane (> 95% pure) in tricaprylin at 20,40 or 100 mg/kg bw (maximum tolerated dose) for a total of 18 or 24 injections (total doses, 360, 960 or 2400 mg/kg bw). Twenty males receiving tricaprylin only were used as controls. Twenty-four weeks after the first injection, all surviving animals were killed; these were 15/20 of the controls, 15/20 at the low dose, 16/20 at the mid-dose and 13/20 at the high dose. The average numbers of lung adenomas per mouse were 0.27 ± 0.015 (SE) in controls, 0.20 ± 0.11 at the low dose, 0.25 ± 0.11 at the mid-dose and 0.85 ± 0.27 at the high dose [proportion of mice with tumours not given]. In a positive control group given a single intraperitoneal injection of urethane at 1000 mg/kg bw, the average number of lung tumours per mouse was 19.6 ± 2.4 (Theiss et al., 1977).

3.2. Other relevant data

(a) Experimental systems

(i) Absorption, distribution, metabolism and excretion

14C-Bromodichloromethane (0.61 mmol/kg bw; 16 μCi/kg bw; 100 mg/kg bw) administered orally in corn oil to rats by gavage was absorbed and eliminated in the expired air as unchanged bromodichloromethane (42% of dose) or as 14C-carbon dioxide (14% of dose) in 8 h; radiolabel amounting to about 1% of the dose was eliminated in the urine, and about 3% of the dose was retained in body tissues. 14C-Bromodichloromethane (0.92 mmol/kg bw; 32 μCi/kg bw; 150 mg/kg bw) administered similarly to mice was absorbed and eliminated in the expired air as unchanged bromodichloromethane (7% of dose) or as 14C-carbon dioxide (81% of dose) in 8 h; about 2% of the administered radiolabel was eliminated in the urine, and 3% was retained in body tissues (Mink et al., 1986). Bromodichloromethane is also metabolized to carbon monoxide in vivo (Anders et al., 1978) and in vitro (Ahmed et al., 1977).

Rats given bromodichloromethane at 0.5 or 5 mg by gavage in corn oil once daily for 25 days showed an average serum concentration of 1 or 23 μg/l and an average fat concentration of 51 or 1800 ng/g (Pfaffenberger et al., 1980); three to five days after dosing had ended, the average serum concentration was 1 μg/l and the average fat concentration was 3–4 ng/g fat for both dose levels.

(ii) Toxic effects

The single-dose oral LD50 of bromodichloromethane (in Emulphor:ethanol: saline 1:1:8) was 450 mg/kg bw in male and 900 mg/kg bw in female ICR Swiss mice (Bowman et al., 1978). Oral LD50 values (in corn oil) of 916 and 969 mg/kg bw were reported in male and female Sprague-Dawley rats (Chu et al., 1980, 1982a), of 651 and 751 mg/kg bw in male and female Fischer 344/N rats and of 300–600 and 651 mg/kg bw in male and female B6C3F! mice (National Toxicology Program, 1987). Signs of acute toxicity in rats included sedation, prostration, lethargy, laboured breathing, ataxia, muscular weakness, anaesthesia and reduction in the number of peripheral lymphocytes (Chu et al, 1980, 1982a; National Toxicology Program, 1987); in mice, sedation and anaesthesia, liver damage including fatty infiltration, kidney lesions and haemorrhage in the adrenal glands, lung and brain were seen (Bowman et al., 1978).

Daily oral treatment of CD-1 mice with 50–250 mg/kg bw bromodichloromethane (in 10% Emulphor in water) for 14 days resulted in decreases in serum glucose in males and increases in transaminases (ALAT and ASAT) and blood urea nitrogen in both males and females treated with 250 mg/kg bw. Decreases in body weight, spleen weight, humoral and cellular immunity and blood fibrinogen as well as increases in liver weight were observed with the highest dose in animals of each sex; some of these effects were also observed with 125 mg/kg bw (Munson et al., 1982). Oral treatment of male CD-1 mice with 37–148 mg/kg bw bromodichloromethane in corn oil for 14 days also led in a dose-dependent fashion to liver damage, as shown by morphological changes, and to increases in serum transaminases (ALAT) at the highest dose level. Morphological and functional changes were observed in the kidney after treatment with the two highest doses (Condie et al., 1983).

Daily oral administration of 150 mg/kg bw bromodichloromethane in corn oil for 14 days was lethal to male but not female B6C3Fi mice, whereas male and female Fischer 344/N rats survived treatment at 600 mg/kg bw. In a 13-week study, male and female Fischer 344/N rats were administered 19–300 mg/kg bw, male B6C3F1 mice were administered 6.25–100 mg/kg bw and female B6C3F1 mice were administered 25–400 mg/kg bw bromodichloromethane in corn oil by gavage on five days per week. In the highest dose groups, treatment was lethal to some rats and resulted in reductions in body weight. Liver and kidney lesions were observed in some of the animals. Atrophy of the thymus, spleen, lymph nodes, seminal vesicles and prostate was observed in rats, the toxicity being less pronounced in females than in males (National Toxicology Program, 1987).

Male and female Sprague-Dawley rats received 5–2500 mg/l bromodichloromethane in drinking-water for 90 days [approximate daily intake, 0.14–49 mg/rat]. The highest concentration resulted in some deaths, mild-to-moderate liver damage, reduction in body weight gain and the number of peripheral lymphocytes and mild changes in the thyroid (Chu et al., 1982b).

Administration of bromodichloromethane in corn oil by gavage for two years (see section 3.1) resulted in kidney damage and fatty changes in the liver in male and female rats (50 or 100 mg/kg bw) and in male (25 or 50 mg/kg bw) but not female (75 or 150 mg/kg bw) mice in all treatment groups. Liver-cell necrosis was observed only in male rats (National Toxicology Program, 1987).

(iii) Effects on reproduction and prenatal toxicity

Sprague-Dawley rats were administered bromodichloromethane in corn oil by gavage at daily doses of 0,50,100 or 200 mg/kg bw on gestation days 6–15 (Ruddick et al., 1983). Maternal weight gain was significantly decreased at the high-dose level; maternal liver weight was significantly increased at all dose levels, and kidney weight was increased at the highest dose level. There was no difference in the incidence of resorptions, litter size or mean fetal weight. There was no increase in the incidence of external or visceral malformations, but aberrations of the sternum were more prevalent at 100 and 200 mg/kg bw than at 50 mg/kg bw.

(iv) Genetic and related effects (Table 5)
Table 5.. Genetic and related effects of bromodichloromethane.

Table 5.

Genetic and related effects of bromodichloromethane.

Bromodichloromethane induced positive responses in some Salmonella typhimurium reverse mutation assays, particularly with strain TA100. Conflicting results were observed in these studies when an exogenous metabolic system was incorporated into the incubation mixture. Generally, the positive results were observed after modifications to the standard assay procedure that resulted in higher doses of the compound reaching the cells, such as exposure in a closed container, a preincubation period or use of a bacterial spot test.

A weak positive response was observed in yeast in a mutation and a gene conversion assay. A mutagenic response was also obtained in L5178Y cells. No sister chromatid exchange was induced in Chinese hamster cells, whereas chromosomal aberrations were observed in two out of three studies. Sister chromatid exchange was observed in one study in human lymphocytes in vitro. Sister chromatid exchange but not micronuclei was induced in mouse bone marrow in vivo.

(b) Humans

No data were available to the Working Group.

3.3. Epidemiological studies of carcinogenicity to humans

A single correlation study (Isacson et al., 1983), described in the monograph on chlorinated drinking-water (p. 113), mentioned bromodichloromethane, but the information could not be used to evaluate the carcinogenicity of this chemical individually.

4. Summary of Data Reported and Evaluation

4.1. Exposure data

Bromodichloromethane is found in chlorinated drinking-water as a consequence of the reaction between chlorine, added during water treatment, and natural organic substances in the presence of bromide. The major route of human exposure to bromodichloromethane is via drinking-water. It has been detected in chlorinated drinking-water in many parts of the world; it has also been detected in some untreated waters, but at much lower levels. Bromodichloromethane is a major component of the organohalides produced by marine algae.

4.2. Experimental carcinogenicity data

Bromodichloromethane was tested for carcinogenicity in two-year studies in male and female Fischer 344 rats and B6C3F1 mice by oral gavage, in life-span studies in male and female Wistar rats and in CBA × C57B1/6 hybrid mice by administration in drinking-water. In the gavage studies, bromodichloromethane increased the incidences of adenomatous polyps and adenocarcinomas of the large intestine and of tubular-cell adenomas and adenocarcinomas of the kidney in male and female rats, of tubular-cell adenomas and adenocarcinomas of the kidney in male mice and of hepatocellular adenomas and carcinomas in female mice. In the study by administration in drinking-water, it induced neoplastic nodules and adenofibrosis of the liver in rats; no increase in tumour incidence was seen in mice. In a screening test for lung adenomas by intraperitoneal injection, bromodichloromethane did not increase the incidence of lung tumours in strain A mice.

4.3. Human carcinogenicity data

No relevant data were available to the Working Group.

4.4. Other relevant data

Repeated exposure of rats and mice to bromodichloromethane resulted in toxic effects in several organs, including the liver and kidney.

A study of developmental toxicity in rats given bromodichloromethane throughout the period of major organogenesis showed skeletal variations in the presence of maternal toxicity but no teratogenic effect.

Bromodichloromethane induced mutations in some studies with bacteria and, in a single study, in cultured mammalian cells. Chromosomal aberrations but not sister chromatid exchange were observed in cultured mammalian cells. In single studies, sister chromatid exchange was observed in cultured human cells and in mouse bone marrow in vivo. In one study, bromodichloromethane did not induce micronuclei in bone-marrow cells of mice treated in vivo.

4.5. Evaluation1

There is inadequate evidence for the carcinogenicity of bromodichloromethane in humans.

There is sufficient evidence for the carcinogenicity of bromodichloromethane in experimental animals.

Overall evaluation

Bromodichloromethane is possibly carcinogenic to humans (Group 2B).

5. References

  • Abdel-Rahman M.S. The presence of trihalomethanes in soft drinks. J. appl. Toxicol. 1982;2:165–166.
  • Ahmed A.E., Kubic V.L., Anders M.W. Metabolism of haloforms to carbon monoxide I. In vitro studies. Drug Metab. Disposition. 1977;5:198–204. [PubMed: 15814]
  • Aldrich Chemical Co. (1990) 1990–1991 Aldrich Handbook of Fine Chemicals, Milwaukee, WI, p. 195.
  • Allgeier, G.D., Mullins, R.L., Jr, Wilding, D.A., Zogorski, J.S. & Hubbs, S.A. (1980) Trihalomethane levels at selected water utilities in Kentucky, USA. In: Afghan, B.K. & Mackay, D., eds, Hydrocarbons and Halogenated Hydrocarbons in the Aquatic Environment, New York, Plenum Press, pp. 473ߝ490.
  • American Tokyo Kasei (1988) TCI American Organic Chemicals 88/89 Catalog, Portland, OR, p. 184.
  • Anders M.W., Stevens J.L., Sprague R.W., Shaath Z., Ahmed A.E. Metabolism of haloforms to carbon monoxide II. In vivo studies. Drug Metab. Disposition. 1978;6:556–560. [PubMed: 30605]
  • Armstrong D.W., Golden T. Determination of distribution and concentration of trihalomethanes in aquatic recreational and therapeutic facilities by electron-capture GC. LC-GC. 1986;4:652–655.
  • Barkley J., Bunch J., Bursey J.T., Castillo N., Cooper S.D., Davis J.M., Erickson M.D., Harris B.S.H. III, Kirkpatrick M., Michael L.C., Parks S.P., Pellizzari E.D., Ray M., Smith D., Tomer K.B., Wagner R., Zweidinger R.A. Gas chromatography mass spectrometry computer analysis of volatile halogenated hydrocarbons in man and his environment—a multimedia environmental study. Biomed. Mass Spectrometry. 1980;7:139–147. [PubMed: 7448328]
  • Bauer U. Human exposure to environmental chemicals—investigations on volatile organic halogenated compounds in water, air, food, and human tissues III. Communication: results of investigations (Ger.). Zentralbl. Bakteriol. Mikrobiol Hyg. Abt. 1 Orig. B. 1981;174:200–237. [PubMed: 7331583]
  • Bellar, T.A., Lichtenberg, J.J. & Kroner, R.C. (1974a) The Occurrence of Organohalides in Chlorinated Drinking Waters (EPA-670/4-74-008; NTIS PB-238 589), Cincinnati, OH, US Environmental Protection Agency.
  • Bellar T.A., Lichtenberg J.J., Kroner R.C. The occurrence of organohalides in chlorinated drinking waters. J Am. Water Works Assoc. 1974b;66:703–706.
  • Bowman F.J., Borzelleca J.F., Munson A.E. The toxicity of some halomethanes in mice. Toxicol. appl. Pharmacol. 1978;44:213–215. [PubMed: 675691]
  • Brass, A.J., Feige, M.A., Halloran, T, Mello, J.W., Munch, D. & Thomas, R.F. (1977) The National Organic Monitoring Survey: samplings and analyses for purgeable organic compounds. In: Pojasek, R.B., ed., Drinking Water Quality Enhancement Through Source Protection, Ann Arbor, MI, Ann Arbor Science, pp. 393–416.
  • Brett R.W., Calverley R.A. A one-year survey of trihalomethane concentration changes within a distribution system. J. Am. Water Works Assoc. 1979;71:515–520.
  • Brodzinsky, R. & Singh, H.B. (1983) Volatile Organic Chemicals in the Atmosphere: An Assessment of Available Data (EPA-600/3-83-027a; NTIS PB83-195503), Research Triangle Park, NC, US Environmental Protection Agency.
  • Bunn W.W., Haas B.B., Deane E.R., Kleopfer R.D. Formation of trihalomethanes by chlorination of surface water. Environ. Lett. 1975;10:205–213. [PubMed: 1213009]
  • Cech I., Smith V., Henry J. Spatial and seasonal variations in concentration of trihalomethanes in drinking water. Pergamon Ser. environ. Sci. 1982;7:19–38.
  • Chemical Information Systems (1990) ISHOW Database, Baltimore, MD.
  • Chu I., Secours V., Marino I., Villeneuve D.C. The acute toxicity of four trihalomethanes in male and female rats. Toxicol. appl. Pharmacol. 1980;52:351–353. [PubMed: 7361328]
  • Chu I., Villeneuve D.C., Secours V.E., Becking G.C. Toxicity of trihalomethanes: I. The acute and subacute toxicity of chloroform, bromo-dichloromethane, chlorodibromomethane and bromoform in rats. J. environ. Sci. Health. 1982a;B17:205–224. [PubMed: 7096898]
  • Chu I., Villeneuve D.C., Secours V.E., Becking G.C. Trihalomethanes: II. Reversibility of toxicological changes produced by chloroform, bromodichloromethane, chlorodibromomethane and bromoform in rats. J. environ. Sci. Health. 1982b;B17:225–240. [PubMed: 7096899]
  • Class T., Kohnle R., Ballschmiter K. Chemistry of organic traces in air. VII: Bromo- and bromochloroethanes in air over the Atlantic Ocean. Chemosphere. 1986;15:429–436.
  • Cole R.H., Frederick R.E., Healy R.P., Rolan R.G. Preliminary findings of the Priority Pollutant Monitoring Project of the Nationwide Urban Runoff Program. Water Pollut. Control Fed. 1984;56:898–908.
  • Coleman W.E., Munch J.W., Kaylor W.H., Streicher R.P., Ringhand H.P., Meier J.R. Gas chromatography/mass spectroscopy analysis of mutagenic extracts of aqueous chlorinated humic acid. A comparison of the byproducts to drinking water contaminants. Environ. Sci. Technol. 1984;18:674–681.
  • Comba M.E., Kaiser K.L.E. Determination of volatile contaminants at the ng/l level in water by capillary gas chromatography with electron capture detection. Int. J. environ. anal. Chem. 1983;16:17–31.
  • Condie L.W., Smallwood C.L., Laurie R.D. Comparative renal and hepatotoxicity of halomethanes: bromodichloromethane, bromoform, chloroform, dibromochloromethane and methylene chloride. Drug chem. Toxicol. 1983;6:563–578. [PubMed: 6653442]
  • DeWalle, F.B. & Chian, E.S.K. (1978) Presence of trace organics in the Delaware River and their discharge by municipal and industrial sources. In: Bell, J.M., ed., Proceedings of the Industrial Waste Conference, Vol. 32, Ann Arbor, MI, Ann Arbor Science, pp. 908–919.
  • Easley D.M., Kleopfer R.D., Carasea A.M. Gas chromatographic-mass spectrometric determination of volatile organic compounds in fish. J. Assoc. off. anal. Chem. 1981;64:653–656. [PubMed: 7240070]
  • Eklund G., Josefsson B., Roos C. Trace analysis of volatile organic substances in Goeteborg municipal drinking water. Vatten. 1978;3:195–206.
  • Entz R.C., Thomas K.W., Diachenko G.W. Residues of volatile halocarbons in foods using headspace gas chromatography. J. agric. Food Chem. 1982;30:846–849.
  • Fedoryński M., Poplawska M., Nitschke K., Kowalski W., Makosza M. A simple method for preparation of dibromochloromethane and bromodichloromethane. Synth. Commun. 1977;7:287–292.
  • de Fernicola N.A.G.G., de Azevedo F.A. Water levels of trihalomethanes (THM) in four different supply systems from Sao Paulo State, (Brazil). J. environ. Health. 1984;46:187–188.
  • Furlong E.A.-N., D'ltri F.M. Trihalomethane levels in chlorinated Michigan drinking water. Ecol. Modelling. 1986;32:215–225.
  • Glaze W.H., Rawley R. A preliminary survey of trihalomethane levels in selected East Texas water supplies. J. Am. Water Works Assoc. 1979;71:509–515.
  • Gschwend P.M., MacFarlane J.K., Newman K.A. Volatile halogenated organic compounds released to seawater from temperate marine macroalgae. Science. 1985;227:1033–1035. [PubMed: 17794227]
  • Hagenmaier H., Werner G., Jäger W. Quantitative determination of volatile halogenated hydrocarbons in water samples by capillary gas chromatography and electron capture detection. Z. Wasser Abwasser Forsch. 1982;15:195–198.
  • Hargesheimer E.E. Identifying water main leaks with trihalomethane tracers. J Am. Water Works Assoc. 1985;77:71–75.
  • Harms, L.L. & Looyenga, R.W (1977) Formation and Removal of Halogenated Hydrocarbons in Drinking Water: A Case Study at Huron, South Dakota (EPA-908/3-77-001; NTTS PB80-159718), Denver, CO, US Environmental Protection Agency.
  • Hayashi M., Kishi M., Sofuni T., Ishidate M. Jr. Micronucleus tests in mice on 39 food additives and eight miscellaneous chemicals. Food chem. Toxicol. 1988;26:487–500. [PubMed: 3169648]
  • Health and Welfare Canada (1977) National Survey for Halomethanes in Drinking Water (Report 77-EHD-9), Ottawa, Environmental Health Directorate, Health Protection Branch.
  • Henderson, J.E., Peyton, G.R. & Glaze, W.H. (1976) A convenient liquid-liquid extraction method for the determination of halomethanes in water at the parts-per-billion level. In: Keith, L.H. ed., Identification and Analysis of Organic Pollutants in Water, Ann Arbor, MI, Ann Arbor Science, pp. 105–111.
  • Hoyt S.D., Rasmussen R.A. Determining trace gases in air and seawater. Adv. Chem. Ser. Mapp. Strategies chem. Oceanogr. 1985;209:31–56.
  • IARC (1987) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7,Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, Lyon, pp. 152–154. [PubMed: 3482203]
  • Isacson, P., Bean, J.A. & Lynch, C. (1983) Relationship of cancer incidence rates in Iowa municipalities to chlorination status of drinking water. In: Jolley, R.J., Brungs, W.A., Cotruvo, Y.A., Cumming, R.B., Mattice, Y.S. & Jacobs, V.A., eds, Water Chlorination-Environmental Impact and Health Effects, Vol. 4, Book 2, Environment, Health, and Risk, Ann Arbor, MI, Ann Arbor Sciences, pp. 1353–1364.
  • Ishidate, M., Jr (1987) Data Book of Chromosomal Aberration Test in vitro, Tokyo, Life-Science Information Center, pp. 49–50.
  • Kaczmar S.W., D'ltri F.M., Zabik M.J. Volatilization rates of selected haloforms from aqueous environments. Environ. Toxicol. Chem. 1984;3:31–35.
  • Kaiser K.L.E., Comba M.E. Volatile contaminants in the Welland River watershed. J. Great Lakes Res. 1983;9:274–280.
  • Kaiser K.L.E., Comba M.E., Huneault H. Volatile halocarbon contaminants in the Niagara River and in Lake Ontario. J. Great Lakes Res. 1983;9:212–223.
  • Kajino, M. & Yagi, M. (1980) Formation of trihalomethanes during chlorination and determination of halogenated hydrocarbons in drinking water. In: Afghan, B.K. & Mackay, D., eds, Hydrocarbons and Halogenated Hydrocarbons in the Aquatic Environment, New York, Plenum Press, pp. 491–501.
  • Kaminski L., von Loew E. Haloforms in swimming pool water (Ger.). Forum Staedte-Hyg. 1984;35:19–20.
  • Khudoley V.V., Mizgireuv I., Pliss G.B. The study of mutagenic activity of carcinogens and other chemical agents with Salmonella typhimurimum assays: testing of 126 compounds. Arch. Geschwulstforsch. 1987;57:453–462. [PubMed: 3435224]
  • Khudoley V.V., Gvildis V. Yu., Pliss G.B. Identification of some trihalomethanes in drinking water and assessment of their toxicity, mutagenicity, and carcinogenicity (Russ.). Vopr. Onkol. 1989;35:837–842. [PubMed: 2773400]
  • Kossik, R.F., Gschwend, P.S. & Adams, E.E. (1986) Tracing and Modeling Pollutant Transport in Boston Harbor (MITSG-86/16; NTIS PB87-136891), Rockville, MD, National Oceanic and Atmospheric Administration.
  • Krasner, S.W., McGuire, M.J., Jacangelo, J.G., Patania, N.L., Reagan, K.M. & Aieta, E.M. (1989) The occurrence of disinfection by-products in drinking water in a nationwide study. In: Annual Conference of the American Water Works Association, Los Angeles, CA, Denver, CO, American Water Works Association.
  • Lahl U., Bätjer K., von Düszeln J., Gabel B., Stachel B., Thiemann W. Distribution and balance of volatile halogenated hydrocarbons in the water and air of covered swimming pools using chlorine for water disinfection. Water Res. 1981;15:803–814.
  • Lahl U., Cetinkaya M., von Duszeln J., Gabel B., Stachel B., Thiemann W. Health risks for infants caused by trihalomethane generation during chemical disinfection of feeding utensils. Ecol. Food Nutr. 1982;12:7–17.
  • Loy, E.W., Jr, Brown, D.W., Stephenson, J.H.M. & Little, J.A. (1976) Uses of wastewater discharge compliance monitoring data. In: Keith, L.H., ed., Identification and Analysis of Organic Pollutants in Water, Ann Arbor, MI, Ann Arbor Science, pp. 499–516.
  • Mabey, W.R., Smith, J.H., Podoll, R.T., Johnson, H.L., Mill, T, Chou, T.W., Gates, J., Waight Partridge, I. & Vandenberg, D. (1982) Aquatic Fate Process Data for Organic Priority Pollutants (EPA-440/4-81-014; NTIS PB87-169090), Washington DC, Office of Water Regulations and Standards, US Environmental Protection Agency, pp. 179–180.
  • McConnell G. Haloorganics in water supplies. J. Inst. Water Eng. Sci. 1976;30:431–445.
  • McGregor D.B., Brown A., Cattanach P., Edwards I., McBride D., Caspary W.J. Responses of the L5178Y tk+/tk mouse lymphoma cell forward mutation assay II: 18 coded chemicals. Environ. mol. Mutagenesis. 1988;11:91–118. [PubMed: 3338442]
  • McKinney, J.D., Maurer, R.R., Hass, J.R. & Thomas R.O. (1976) Possible factors in the drinking water of laboratory animals causing reproductive failure. In: Keith, L.H., ed., Identification and Analysis of Organic Pollutants in Water, Ann Arbor, MI, Ann Arbor Science, pp. 417–432.
  • Mersch-Sunderman V. Examination of the mutagenicity of organic microcontaminations in the environment II. The mutagenicity of halogenated aliphatic hydrocarbons with the Salmonella-microsome, test (Ames test) in relation to contamination of ground- and drinking-water (Ger.). Zbl. Bakt. Hyg. B. 1989;187:230–243. [PubMed: 2494817]
  • Minear, R.A. & Morrow, C.M. (1983) Raw Water Bromide: Levels and Relationship to Distribution of Trihalomethanes in Finished Drinking Water (OWRT-A-063-TENN; NTIS PB83-256735), Washington DC, US Environmental Protection Agency.
  • Mink F.L., Brown T.J., Rickabaugh J. Absorption, distribution, and excretion of 14C-trihalomethanes in mice and rats. Bull. environ. Contam. Toxicol. 1986;37:752–758. [PubMed: 3779162]
  • Morimoto, K. & Koizumi, A. (1983) Trihalomethanes induce sister chromatid exchanges in human lymphocytes in vitro and mouse bone marrow cells in vivo. Environ. Res., 32,72–79. [PubMed: 6617620]
  • Mortelmans, K., Haworth, S., Lawlor, T, Speck, W, Tainer, B. & Zeiger, E. (1986) Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ. Mutagenesis, 8 (Suppl. 7), 1–119. [PubMed: 3516675]
  • Munson, A.E., Sain, L.E., Sanders, V.M., Kauffmann, B.M., White, K.L., Page, D.G., Barnes, D.W. & Borzelleca, J.F. (1982) Toxicology of organic drinking water contaminants: trichloromethane, bromodichloromethane, dibromochloromethane and tribromomethane. Environ. Health Perspect., 46,117–126. [PMC free article: PMC1569032] [PubMed: 7151752]
  • National Library of Medicine (1989) TRI (Toxic Chemical Release Inventory Data Bank), Bethesda, MD.
  • National Toxicology Program (1987) Toxicology and Carcinogenesis Studies of Bromo-dichloromethane (CAS No. 75-27-4) in F344IN Rats and B6C3F1 Mice (Gavage Studies) (NTP Technical Report Series No. 321), Research Triangle Park, NC, US Department of Health and Human Services.
  • Nestmann E.R., Lee E.G.-H. Genetic activity in Saccharomyces cerevisiae of compounds found in effluents of pulp and paper mills. Mutat. Res. 1985;155:53–60. [PubMed: 3881665]
  • Norin H., Renberg L., Hjort J., Lundblad P.O. Factors influencing formation of trihalomethanes in drinking water with special reference to Swedish conditions. Chemosphere. 1981;10:1265–1273.
  • Oliver B.G. Dihaloacetonitriles in drinking water: algae and fulvic acid as precursors. Environ. Sci. Technol. 1983;17:80–83. [PubMed: 22295957]
  • Otson R. Purgeable organics in Great Lakes raw and treated water. Int. J. environ. anal. Chem. 1987;31:41–53.
  • Otson R., Williams D.T., Bothwell P.D., Quon T.K. Comparison of trihalomethane levels and other water quality parameters for three treatment plants on the Ottawa River. Environ. Sci. Technol. 1981;15:1075–1080. [PubMed: 22284113]
  • Otson, R., Williams, D.T. & Bothwell, P.D. (1982) Volatile organic compounds in water at thirty Canadian potable water treatment facilities. J. Assoc. off. anal. Chem., 65,1370–1374.
  • Peoples, A.J., Pfaffenberger, CD., Shafik, T.M. & Enos, H.F. (1979) Determination of volatile purgeable halogenated hydrocarbons in human adipose tissue and blood serum. Bull, environ. Contam. Toxicol., 23, 244–249. [PubMed: 497433]
  • Perwak, J., Goyer, M., Harris, J., Schimke, G., Scow, K., Wallace, D. & Slimak, M. (1980) An Exposure and Risk Assessment for Trihalomethanes: Chloroform, Bromoform, Bromodi-chloromethane, Dibromochloromethane (EPA-440/4-81-018; NTIS PB85-211977), Washington DC, Office of Water Regulations and Standards, US Environmental Protection Agency.
  • Pfaffenberger C.D., Peoples A.J., Enos H.F. Distribution of volatile halogenated organic compounds between rat blood serum and adipose tissue. Int. J. environ, anal. Chem. 1980;8:55–65. [PubMed: 7399799]
  • Pouchert, C.J., ed. (1974) The Aldrich Library of NMR Spectra, Vol. 1, Milwaukee, WI, Aldrich Chemical Co., p. 64C.
  • Pouchert, C.J., ed. (1981) The Aldrich Library of Infrared Spectra, 3rd ed., Milwaukee, WI, Aldrich Chemical Co., p. 52A.
  • Pouchert, C.J., ed. (1983) The Aldrich Library of NMR Spectra, 2nd ed., Vol. 1, Milwaukee, WI, Aldrich Chemical Co., p. 82B.
  • Pouchert, C.J., ed. (1985a) The Aldrich Library of FT-IR Spectra, Vol. 1, Milwaukee, WI, Aldrich Chemical Co., p. 83C.
  • Pouchert, C.J., ed. (1985b) The Aldrich Library of FT-IR Spectra, Vol. 3, Milwaukee, WI, Aldrich Chemical Co., p. 116D.
  • Quaghebeur, D. & De Wulf, E. (1980) Volatile halogenated hydrocarbons in Belgian drinking waters. Sci. total Environ., 14, 43–52.
  • Reding, R., Fair, RS., Shipp, C.J. & Brass, H.J. (1989) Measurement of dihaloacetonitriles and chloropicrin in US drinking waters. In: Disinfection By-products: Current Perspectives, Denver, CO, American Water Works Association, pp. 11–22.
  • Riedel-de Haën (1986) Laboratory Chemicals 1986, Seelze 1/Hannover, p. 154.
  • Rodriguez-Flores, M. (1983) Characterization of Organic Contaminants in Selected Potable Water Supplies in Puerto Rico (OWRT-A-057-PR; NTIS PB83-178038), Washington DC, US Environmental Protection Agency.
  • Rook J.J. Formation of haloforms during chlorination of natural waters. Water Treat Exam. 1974;23:234–243.
  • Ruddick, J.A., Villeneuve, D.C. & Chu, I. (1983) A teratological assessment of four trihalomethanes in the rat. J environ. Sci. Health, B18, 333–349. [PubMed: 6875216]
  • Sadtler Research Laboratories (1980) The Sadtler Standard Spectra, 1980 Cumulative Index Philadelphia, PA.
  • Scotte P. Study of halogenated organic compounds in covered swimming pools (Fr). Eau Ind. Nuisances. 1984;86:37–41.
  • Simmon, V.F., Kauhanen, K. & Tardiff, R.G. (1977) Mutagenic activity of chemicals identified in drinking water. In: Scott, D., Bridges, B.A. & Sobels, F.H., eds, Progress in Genetic Toxicology, Amsterdam, Elsevier/North-Holland Biomedical Press, pp. 249–258.
  • Sittig, M. (1985) Handbook of Toxic and Hazardous Chemicals and Carcinogens, 2nd ed., Park Ridge, NJ, Noyes Publications, pp. 148–149.
  • Smith R.L. A computer assisted, risk-based screening of a mixture of drinking water chemicals. Trace Subst. environ. Health. 1989;22:215–232.
  • Standing Committee of Analysts (1980) Chloro and Bromo Trihalogenated Methanes in Water (Methods for the Examination of Waters and Associated Materials), London, Her Majesty's Stationery Office.
  • Stevens, A.A., Moore, L.A., Slocum, C.J., Smith, B.L., Seeger, D.R. & Ireland, J.C. (1989) By-products of chlorination at ten operating utilities. In: Disinfection By-products: Current Perspectives, Denver, CO, American Water Works Association, pp. 23–61.
  • Strobel K., Grummt T. Aliphatic and aromatic halocarbons as potential mutagens in drinking water Part I. Halogenated methanes. Toxicol. environ. Chem. 1987;13:205–221.
  • Symons, J.M., Bellar, T.A., Carswell, J.K., DeMarco, J., Kropp, K.L., Robeck, G.G., Seeger, D.R., Slocum, C.J., Smith, B.L. & Stevens, A.A. (1975) National Organics Reconnaissance Survey for halogenated organics. J Am. Water Works Assoc., 67,634–647.
  • Theiss J.C., Stoner G.D., Shimkin M.B., Weisburger E.K. Test for carcinogenicity of organic contaminants of United States drinking waters by pulmonary tumor response in strain A mice. Cancer Res. 1977;37:2717–2720. [PubMed: 872098]
  • Trussell, A.R., Cromer, J.L., Umphres, M.D., Kelley, RE. & Moncur, J.G. (1980) Monitoring of volatile halogenated organics: a survey of twelve drinking waters from various parts of the world. In: Jolley, R.L., Brungs, W.A., Cumming, R.B. & Jacobs, V.A., eds, Water Chlorination: Environmental Impact and Health Effects, Vol. 3, Ann Arbor, MI, Ann Arbor Science, pp. 39–53.
  • Tumasonis C.F., McMartin D.N., Bush B. Lifetime toxicity of chloroform and bromodichloromethane when administered over a lifetime in rats. Ecotoxicol. environ Saf. 1985;9:233–240. [PubMed: 3987603]
  • Uhler A.D., Diachenko G.W. Volatile halocarbon compounds in process water and processed foods. Bull. environ. Contam. Toxicol. 1987;39:601–607. [PubMed: 3689989]
  • Ullrich D. 7 Organohalogen compounds in the air of some public swimming pools in Berlin (Ger.). WaBoLu-Ber. 1982;1:50–52.
  • US Environmental Protection Agency (1985) Health and Environmental Effects Profile for Bromochloromethanes (EPA-600/X-85-397; NTIS PB88-174610), Cincinnati, OH, Environmental Criteria and Assessment Office.
  • US Environmental Protection Agency (1986a) Method 8010. Halogenated volatile organics. In: Test Methods for Evaluating Solid Waste—Physical/Chemical Methods, 3rd ed. (EPA No. SW-846), Washington DC, Office of Solid Waste and Emergency Response.
  • US Environmental Protection Agency (1986b) Method 8240. Gas chromatography/mass spectrometry for volatile organics. In: Test Methods for Evaluating Solid Waste—Physical/Chemical Methods, 3rd ed. (EPA No. SW-846), Washington DC, Office of Solid Waste and Emergency Response.
  • US Environmental Protection Agency (1988a) Methods for organic chemical analysis of municipal and industrial wastewater. Method 601. Purgeable halocarbons. US Code fed. Regul., Title 40, Part 136, Appendix A, pp. 267–281.
  • US Environmental Protection Agency (1988b) Methods for organic chemical analysis of municipal and industrial wastewater. Method 624. Purgeables. US Code fed. Regul., Title 40, Part 136, Appendix A, pp. 432–446.
  • US Environmental Protection Agency (1988c) Method 502.2. Volatile organic compounds in water by purge and trap capillary column gas chromatography with photoionization and electrolytic conductivity detectors in series. Revision 2.0. In: Methods for the Determination of Organic Compounds in Drinking Water (PB89-220461 EPA-600/4-88 039), Cincinnati, OH, Environmental Monitoring Systems Laboratory, pp. 31–62.
  • US Environmental Protection Agency (1988d) Method 524.2. Measurement of purgeable organic compounds in water by capillary column gas chromatography/mass spectrometry. Revision 3.0. In: Methods for the Determination of Organic Compounds in Drinking Water (PB89-220461, EPA-600/4-88 039), Cincinnati, OH, Environmental Monitoring Systems Laboratory, pp. 285–323.
  • US Environmental Protection Agency (1988e) Methods for organic chemical analysis of municipal and industrial wastewater. Method 1624 Revision B. Volatile organic compounds by isotope dilution GC/MS. US Code fed. Regul., Title 40, Part 136, Appendix A, pp. 475–488.
  • US Environmental Protection Agency (1988f) Analysis of trihalomethanes. Part II—Analysis of trihalomethanes in drinking water by liquid/liquid extraction. US Code fed. Regul., Title 40, Part 141, Appendix C, pp. 563–571.
  • Varma M.M., Ampy F.R., Verma K., Talbot W.W. In vitro mutagenicity of water contaminants in complex mixtures. J. appl. Toxicol. 1988;8:243–248. [PubMed: 3183290]
  • Verschueren, K. (1983) Handbook of Environmental Data on Organic Chemicals, 2nd ed., New York, Van Nostrand Reinhold, p. 291.
  • Voronin V.M., Donchenko A.I., Korolev A.A. Experimental study of the carcinogenicity of dichlorobromomethane and dibromochloromethane formed during chlorination of water (Russ.). Gig. Sanit. 1987;1:19–21. [PubMed: 3817487]
  • Wallace L., Zweidinger R., Erickson M., Cooper S., Whitaker D., Pellizzari E. Monitoring individual exposure Measurements of volatile organic compounds in breathing-zone air, drinking water, and exhaled breath. Environ. int. 1982;8:269–282.
  • Wallace L., Pellizzari E., Hartwell T., Rosenzweig M., Erickson M., Sparacino C., Zelon H. Personal exposure to volatile organic compounds I. Direct measurements in breathing-zone air, drinking water, food, and exhaled breath. Environ. Res. 1984;35:293–319. [PubMed: 6489295]
  • Weast, R.C., ed. (1989) CRC Handbook of Chemistry and Physics, 70th ed., Boca Raton, FL, CRC Press, p. C-348.
  • Weil L., Jandik J., Eichelsdoefer D. Organic halogenated compounds in swimming pool water I. Determination of volatile halogenated hydrocarbons (Ger.). Z. Wasser Abwasser Forsch. 1980;13:141–145.
  • Westrick J.J., Mello J.W., Thomas R.F. The groundwater supply survey. J. Am Water Works Assoc. 1984;76:52–59.
  • Williams, D.T. (1985) Formation of trihalomethanes in drinking water. In: Fishbein, L. & O'Neill, I.K., eds, Environmental Carcinogens. Selected Methods of Analysis, Vol. 7, Some Volatile Halogenated Hydrocarbons (IARC Scientific Publications No. 68), Lyon, IARC, pp. 69–88.

Footnotes

1

In square brackets, spectrum number in compilation

1

Calculated from: mg/m3 = (molecular weight/24.45) X ppm, assuming standard temperature (25°C) and pressure (760 mm Hg)

1

For definition of the italicized terms, see Preamble, pp. 30–33.

©International Agency for Research on Cancer, 1991.
Bookshelf ID: NBK506906

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (31M)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...